NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

计划入组 144 人 · 首次发布于 2025 年 12 月 30 日

Tumour Characterisation to Guide Experimental Targeted Therapy - National

计划入组 6,000 人 · 首次发布于 2021 年 1 月 25 日

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

计划入组 106 人 · 首次发布于 2022 年 5 月 31 日

NU-0129

PMTA (Sinfonia Biotherapeutics)

FCBL

Targeted Therapy Technologies, LLC

United States

TARGETED GENETICS CORPORATION

United States

TLA Targeted Immunotherapies AB

Sweden

Claudin 18.2-Targeted Therapies Show Promise in Gastric and Other Cancers

Targeted Therapies Show Promise in High-Grade Serous Ovarian Cancer Treatment

Nicklaus Children’s Hospital Advances Pediatric Cancer Treatment with Targeted Therapy